Market Context — Why This Technology, Why Now

Rising global prevalence of chronic diseases like non-alcoholic steatohepatitis (NASH) and neurodegenerative disorders is driving urgent demand for advanced diagnostic tools. MRE offers a non-invasive method to assess tissue elasticity, crucial for early detection and monitoring. This technology's ability to standardize MRE analysis and improve data quality aligns perfectly with the shift towards objective, data-driven diagnostics and precision medicine, making it a critical asset for healthcare innovation worldwide.

Key Competitive Advantages
01

Significantly Improves Diagnostic Accuracy and Reproducibility: Utilizes automated region setting, independent of user subjectivity, to dramatically enhance MRE image reliability and increase elasticity measurement precision and reproducibility.

02

Optimizes Examination Efficiency and Data Quality: Automatically adjusts the discrimination region size based on propagation wavelength, supporting optimal data acquisition during examinations and streamlining the diagnostic process.

03

Establishes Market Advantage Through High Uniqueness: The technology's distinctiveness is highlighted by only two prior art documents cited by the examiner, suggesting strong potential for early market share capture.

Market Opportunity
Medical Diagnostics (Liver Disease)
$1.0B–$2.0B globally (AI est.)
The increasing incidence of liver diseases like Non-Alcoholic Steatohepatitis (NASH) drives demand for non-invasive MRE methods to assess liver fibrosis.
Major medical imaging equipment manufacturers Specialized diagnostic service providers Healthcare AI solution developers
Medical Diagnostics (Neurological Disorders)
$0.5B–$1.5B globally (AI est.)
There is growing interest in MRE as a diagnostic technique to detect early elastic changes in brain tissue for neurodegenerative diseases such as Alzheimer's and Parkinson's.
Neurological diagnostic device companies Research institutions focused on brain health Digital health platforms for neuro-monitoring
Pharmaceutical & Research Institutions
$600M–$700M globally (AI est.)
High-precision MRE technology is sought for non-invasive evaluation of treatment efficacy in new drug development and for analyzing biological tissue properties in basic research.
Pharmaceutical companies for drug development Academic research centers Contract Research Organizations (CROs)
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent specifically protects the configuration of an imaging apparatus centered on 'region size adjustment means' and 'discrimination means' for MRE image analysis. Its strong originality was recognized with only two prior art documents cited by the examiner, leading to a swift patent grant and indicating a stable and robust scope of protection.

Competitive White Space

While this patent secures core MRE image analysis algorithms, white space exists in developing novel MRE hardware components, integrating MRE with other multi-modal imaging techniques, or exploring new applications in non-medical fields like material science or industrial inspection.

Economic Impact
~$1.0M/year estimated diagnostic cost reduction and opportunity loss mitigation (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Assuming a medium-sized hospital conducts 5,000 MRE examinations annually, with a cost of $200/examination (AI est.). Implementing this technology could reduce the re-examination rate by 7% (from 10% to 3%), eliminating 350 re-examinations annually (5,000 cases × 7% = 350 cases). This results in direct cost savings of $70K/year (AI est.) (350 cases × $200). Including indirect benefits such as improved patient throughput from faster, more accurate diagnoses, reduced medical litigation risk from fewer misdiagnoses, and enhanced treatment efficacy through early detection, the total economic impact is estimated at ~$1.0M/year (AI est.).

Speed to Market
4× faster than in-house development
Developing MRE image analysis technology in-house, from basic research to algorithm establishment and clinical validation, is estimated to take approximately 4 years. This technology, however, features an already established vibration wave analysis algorithm and core MRE image creation technology protected by patent. This allows adopting companies to focus on software integration or module addition to existing MRI systems, potentially shortening time-to-market by ~3.0 years, enabling faster business deployment and monetization.
Competitive Positioning

X: Diagnostic Reproducibility
Y: Examination Efficiency

Business Models & Applications
🤝 Licensing to Diagnostic Equipment Manufacturers
License this technology's image analysis software module or hardware components to existing MRI device manufacturers, enhancing their product competitiveness.
☁️ MRE Image Analysis Service Provision
Receive MRE image data from medical institutions and provide high-precision elasticity analysis reports using this technology via a cloud-based service.
🏥 OEM for Specific Disease Diagnostic Devices
Integrate this technology into MRE imaging devices specialized for specific disease diagnostics, such as liver fibrosis or neurological disorders, and supply them as OEM products to establish market leadership.
Adjacent Application Opportunities
🏗️ Non-Destructive Testing
Internal Defect Detection for Industrial Structures
This technology could be repurposed for non-destructive, high-precision detection of fatigue cracks or internal defects in industrial structures like bridges and aircraft components, which are invisible to the naked eye, by analyzing minute vibration waves propagating within them. This could enhance infrastructure safety management and product quality inspection efficiency by up to 20%.
🌱 Agriculture & Food
Non-Invasive Quality Assessment for Produce
The technology could be applied to objectively assess the freshness, ripeness, and presence of quality degradation in food products such as fruits, vegetables, and meat, by non-invasively measuring their internal tissue's elastic properties. This has the potential to reduce food waste by 15-20% and contribute to the selection and distribution of high-quality agricultural products.
🔬 Materials Science
Microstructure and Elastic Property Evaluation for New Materials
In the development of new materials like polymers, composites, and biomimetic materials, this technology could serve as a high-precision, non-destructive device for evaluating internal microstructures and elastic anisotropy. This could accelerate material functional design and quality control processes, potentially shortening research and development cycles by ~25%.
Integration Roadmap — Estimated 18-Month Deployment
Phase 1: Technical Validation & Requirements Definition
Duration: 3 months
Evaluate the compatibility of this technology's MRE analysis algorithm with the licensee's existing MRI system. Define detailed functional requirements and performance targets.
Phase 2: System Development & Prototype Construction
Duration: 9 months
Develop the image analysis module based on defined requirements. Integrate it into the existing system and conduct prototype operational verification.
Phase 3: Clinical Validation & Market Launch
Duration: 6 months
Perform performance evaluation in a clinical environment using the prototype. After confirming compliance with regulatory requirements, aim for product commercialization and full market introduction.
Technical Feasibility
This technology is structured as a software algorithm that performs a series of processes—region size adjustment, vibration primary direction discrimination, and MRE image creation—on MR phase image data obtained from MRI devices. Therefore, it possesses the technical feasibility for relatively easy integration into existing general-purpose MRI imaging devices through software updates to the image data processing unit or the addition of a dedicated module. As it does not involve extensive hardware modifications, the barrier to adoption is considered low.
Success Scenario
Upon adopting this technology, healthcare institutions could significantly enhance the objectivity and reproducibility of MRE diagnoses. This is expected to improve the accuracy of early diagnosis for liver and neurological diseases, enabling prompt and appropriate treatment interventions for patients. Furthermore, automation of the examination process could reduce the burden on technicians, potentially leading to an estimated ~10% reduction in examination time and improved patient throughput.
Patent Record
APPLICATION NO.
特願2021-113419
REGISTRATION NO.
7570693
FILING DATE
2021/07/08
GRANT DATE
2024/10/11
EXPIRATION DATE
2041/07/08
PATENT HOLDER
東京都公立大学法人
Examination History
2024年04月05日
出願審査請求書
2024年10月01日
特許査定